Synonyms: Ivacaftor-D9 | VX-561 | VX561
deutivacaftor is an approved drug
Compound class:
Synthetic organic
Comment: Deutivacaftor (VX-561) is a deuterated analogue of ivacaftor. The principal action of this small molecule is as a cystic fibrosis transmembrane conductance regulator (CFTR) potentiator that increases CFTR chloride channel opening. Deuteration is a strategy that is used to improve the stability and half-life of small molecule drugs.
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
Approved drug? | Yes. FDA (2024) |
IUPAC Name ![]() |
N-[2-tert-butyl-4-[1,1,1,3,3,3-hexadeuterio-2-(trideuteriomethyl)propan-2-yl]-5-hydroxyphenyl]-4-oxo-1H-quinoline-3-carboxamide |
International Nonproprietary Names ![]() |
|
INN number | INN |
10704 | deutivacaftor |
Synonyms ![]() |
Ivacaftor-D9 | VX-561 | VX561 |
Database Links ![]() |
|
CAS Registry No. | 1413431-07-8 (source: WHO INN record) |
ChEMBL Ligand | CHEMBL4297603 |
DrugBank Ligand | DB15141 |
GtoPdb PubChem SID | 507750329 |
PubChem CID | 71470491 |
Search Google for chemical match using the InChIKey | PURKAOJPTOLRMP-ASMGOKTBSA-N |
Search Google for chemicals with the same backbone | PURKAOJPTOLRMP |
Search PubMed clinical trials | deutivacaftor |
Search PubMed titles | deutivacaftor |
Search PubMed titles/abstracts | deutivacaftor |
UniChem Compound Search for chemical match using the InChIKey | PURKAOJPTOLRMP-ASMGOKTBSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | PURKAOJPTOLRMP-ASMGOKTBSA-N |